FDA’s July activities report on the generic drugs program shows an increasing pace to ANDA approvals. After a slow start to the first quarter, the number of approvals reached 74 in June.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
